THE SOUTH AFRICAN
DEPRESSION AND ANXIETY
GROUP

facebooktwitter

IN THE WORKPLACE

New Research on Depression in the Workplace.

For more information please click here

business

SADAG NEWSLETTER

To subscribe to SADAG's newsletter, click here

JOURNAL

Mental Health Matters Journal for Psychiatrists & GP's

MHM September 207x300

Click here for more info on articles & how to subscribe

SPEAKING BOOKS

suicide book

Literacy is a luxury that many of us take for granted.  We depend on written communication for information, guidance, and access to heath care information That is why SADAG created SPEAKING BOOKS and revolutionized the way information is delivered to low literacy communities. It's exactly what it sounds like.a book that talks to the reader in his or her local  language, delivering critical information in an interactive, and educational way.

The customizable 16-page book, accompanied by local celebrity audio recordings, ensures that vital health and social messages can be seen, heard, read and understood..

We started with books on Teen Suicide prevention , HIV, AIDS and Depression, Understanding Mental Health and have developed over 30 titles, such as TB, Malaria, Polio, Vaccines for over 30 countries.

depression book

Summary

To evaluate the impact of the transition into menopause on mood disorders in women with no previous history of major depression, 460 premenopausal women between the ages of 36 and 45 were enrolled and followed for up to 92 months. Over this period, 326 women entered the perimenopausal stage while 134 remained in the premenopausal stage. The Center for Epidemiological Studies Depression Scale was used to assess new onset depression; the Life Experience Survey was administered to evaluate negative life events over the study time course.

Women who entered the perimenopausal phase were twice as likely to develop a depressive syndrome as women who remained premenopausal. Women who reported vasomotor symptoms such as hot flashes were somewhat more likely to develop depressive symptoms. Use of hormone therapy to ease the symptomatic transition into menopause did not seem to impact the rate of depressive symptom onset. Women with a history of significant negative life events were more prone to developing depressive symptoms compared with women who remained premenopausal.

Viewpoint

This study helps solidify evidence that transition to menopause is associated with an increased risk for the development of a depressive syndrome. Previous studies defined menopause merely by age or with a variety of criteria including hormone levels, presence of menopausal-related symptoms, or history of menstrual cycle irregularity.[1,2] Strengths of the current study include:

  • Provision of a more rigorous definition of transition into the menopausal state;
  • Evaluation of women with no previous depression history; and
  • Assessment of how vasomotor symptoms impact development of depression.

The milder degree of depressive symptoms in those taking hormone therapy compared with those not taking hormone therapy hints at the possibility of a protective effect from hormone therapy in this population.

Self-reports of symptoms of depression and absence or presence of vasomotor symptoms is a possible study limitation. These subjective assessments may not be as accurate as more objective means to determine this information.

Nonetheless, this well-designed, prospective, longitudinal study enhances our understanding of an area of women's health that, until recently, has been largely ignored.

 

Our Sponsors

Our Partners